All stock lists
Critical Metals Corp. (NASDAQ:CRML)
US · Delayed Price · Currency is USD
Basic Materials · Industrial Materials
6.25-0.53 (-7.82%)
Market cap
$919M
Insider Score
Health Score
Analyst consensus
Listed since
Feb 7, 2022
Website
Insider Score
––Not scored
CRML Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Financial Health Score
Weak
From CRML’s reported statements · Q2 2026 (trailing 12 months)
Profitability0 / 20
Loses money on what it sells.
- Revenue
- $1.9M
- Net income
- -$228.2M
- Net margin
- -12085.9%
Leverage20 / 20
Little or no net debt.
- Total debt
- $6.5M
- Cash
- $102.5M
- Debt / equity
- 0.02
Liquidity5 / 20
Owes more within a year than it holds to pay it.
- Current assets
- $104.6M
- Current liabilities
- $120.1M
- Current ratio
- 0.87
Cash generation0 / 20
Consumes cash and must keep raising it.
- Operating cash flow
- -$29.7M
- Free cash flow
- -$42.6M
- FCF margin
- -2257.3%
Dilution & runway0 / 20
Heavy dilution — shareholders are paying for the business.
- Shares outstanding
- 131.5M
- Share growth (1y)
- 36.4%
- Cash runway
- 41 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
CRML Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 660.17 K | 660.17 K | 283.90 K | 283.90 K | 100.38 K | 100.38 K |
| Revenue Growth (YoY) | 557.66 % | 557.66 % | 57.79 % | 57.79 % | 70.63 % | 70.63 % |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 660.17 K | 660.17 K | 283.90 K | 283.90 K | 100.38 K | 100.38 K |
| SG&A Expense | 27.23 M | 27.83 M | 13.08 M | 13.08 M | 13.18 M | 13.18 M |
| R&D Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 27.83 M | 27.83 M | 13.08 M | 13.08 M | 13.18 M | 13.18 M |
| Operating Income | -27.17 M | -27.17 M | -12.80 M | -12.80 M | -13.07 M | -13.07 M |
| Pretax Income | -53.93 M | -53.93 M | -60.19 M | -60.19 M | -18.75 M | -18.75 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -53.91 M | -53.91 M | -60.19 M | -60.19 M | -18.75 M | -18.75 M |
| EPS (Basic) | -0.41 | -0.41 | -0.53 | -0.53 | -0.19 | -0.19 |
| EPS (Diluted) | -0.41 | -0.41 | -0.53 | -0.53 | -0.19 | -0.19 |
| Shares Outstanding | 131.55 M | 131.55 M | 112.50 M | 112.50 M | 96.42 M | 96.42 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.